Stay updated on DTG vs EFV for HIV-TB Coinfection Clinical Trial
Sign up to get notified when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.

Latest updates to the DTG vs EFV for HIV-TB Coinfection Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated to include new facility names and locations, as well as updated drug information for Dolutegravir and Efavirenz. Additionally, several MedlinePlus related topics have been added, enhancing the content related to HIV.SummaryDifference2%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.SummaryDifference0.5%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.0%
Stay in the know with updates to DTG vs EFV for HIV-TB Coinfection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTG vs EFV for HIV-TB Coinfection Clinical Trial page.